Inventor

MOUSA SHAKER A

US57 patents

⚠️ This page may combine multiple inventors who share the name “MOUSA SHAKER A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MOUSA SHAKER A

MOUSA SHAKER A

Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof

Thyroid hormone analogs and methods of use

Thyroid hormone analogs and methods of use

Nanoformulation of vitamin D derivatives and/or vitamin D metabolites

Formulations of factor VIIa inhibitors and utility

Oxidized heparin fractions and their use in inhibiting angiogenesis

Thyroid hormone analogs and methods of use

Compositions and methods of natural products in nanoformulations for the prevention and treatment of osteoporosis

Ocular nanoformulation and method of use in angiogenesis-mediated disorders

Silver nanoparticles as anti-microbial

Composition and method of use for combinations of anti-viral protease, polymerase inhibitors and natural bioactive compounds in the treatment of hepatitis C infection

Nanoformulation and methods of use of thyroid receptor beta1 agonists for liver targeting

Compositions and method for anti-sickling of red blood cells in sickle cell disease

Nano-targeted delivery of protease, polymerase inhibitors with or without immune modulators in the treatment of hepatitis C

Method and composition of glycosaminoglycans in sickle cell and vascular disorders

Formulations of Factor VIIa inhibitors and utility

Compositions of dual thyrointegrin antagonists and use in vascular-associated disorders

Thyroid hormone analogs and methods of use

Compositions of novel bone patch in bone and vascular regeneration

NANOPHARMACEUTICALS LLC

Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof

Method and composition of thyroid hormone analogues and nanoformulations thereof for treating inflammatory disorders

Method and composition of thyroid hormone analogues and nanoformulations thereof for treating anti-inflammatory disorders

Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof

Non-cleavable polymer conjugated with αVβ3 integrin thyroid antagonists

Composition of scalable thyrointegrin antagonists with improved blood brain barrier penetration and retention into brain tumors

Composition of scalable thyrointegrin antagonists with improved retention in tumors

Polymer conjugated thyrointegrin antagonists

Non-cleavable polymer conjugated with alpha V beta 3 integrin thyroid antagonists

SHIFA BIOMEDICAL CORP

Anti-PCSK9 compounds and methods for the treatment and/or prevention of cardiovascular diseases

Anti-proprotein convertase subtilisin kexin type 9 (anti-PCSK9) compounds and methods of using the same in the treatment and/or prevention of cardiovascular diseases

Anti-proprotein convertase subtilisin kexin type 9 (anti-PCSK9) compounds and methods of using the same in the treatment and/or prevention of cardiovascular diseases

Anti-proprotein convertase subtilisin kexin type 9 (anti-PCSK9) compounds and methods of using the same in the treatment and/or prevention of cardiovascular diseases

Anti-proprotein convertase subtilisin kexin type 9 (anti-PCSK9) nano-formulation of compounds and methods of using the same

DAVIS PAUL J

Uses of formulations of thyroid hormone analogs and nanoparticulate forms thereof to increase chemosensitivity and radiosensitivity in tumor or cancer cells

Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations and uses thereof

Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations and uses thereof

Virothera Pharmaceuticals LLC

Method and composition for treating upper respiratory tract inflammatory and infectious diseases

Method for treatment of a viral-mediated infectious disease

Environmentally natural protective and therapeutic (ENPT) face mask

BRISTOL MYERS SQUIBB PHARMA CO

Inhibition of angiogenesis by antibodies against high molecular weight kininogen domain 5

Synergy between low molecular weight heparin and platelet aggregation inhibitors, providing a combination therapy for the prevention and treatment of various thromboembolic disorders

UNIV TEMPLE

Inhibition of angiogenesis by peptide analogs of high molecular weight kininogen domain 5

Treatment of disease with antibodies against high molecular weight kininogen domain 5

DU PONT MERCK PHARMA

Cyclic compounds useful as inhibitors of platelet glycoprotein IIB/IIIA

ORDWAY RES INST INC

Thyroid hormone analogs and methods of use

EL-NAGGAR MAWAHEB M

Method and system with contact lens product for treating and preventing adverse eye conditions

ALEXANDER-BRIDGES MARIA

Methods of stimulating fat mobilization using a polymer conjugated polyphenol

LIN HUNG-YUN

Combination treatment of cancer with cetuximab and tetrac

(unassigned)

Prevention and treatment of tumor growth, metastasis, and thromboembolic complications in cancer patients

MOUSA DEENA S

Composition and method for stopping hemorrhage, infection, and accelerating healing in various types of wound or burns